Answers are grounded in this paper and cite their sources.
Review reveals limitations in current advanced HCC therapies, suggesting precision oncology strategies.
The therapeutic landscape for advanced HCC has expanded with ICI combinations, yet durable survival remains limited—an efficacy paradox from regimen proliferation without consistent long-term benefit, reflecting persistent biological constraints. We replace the trial-chronology approach with a mechanism-driven framework integrating the immunological basis of the HCC 'cold' microenvironment, liver immune tolerance and immune-privileged regulation, ICI–TKI-induced microenvironment remodeling, and how etiologic heterogeneity and dynamic resistance shape durability. This synthesis reveals three key limitations: First, low intrinsic immunogenicity and constrained de novo immune generation restrict sustained checkpoint blockade-induced anti-tumor immunity. Second, ICI–TKI synergy is target-mediated rather than serendipitous: TKIs remodel the microenvironment to create a time-limited window for ICI action, not merely potentiating pre-existing immunity. Third, the biomarker void and etiology-related differences prevent reliable patient matching, fostering an illusion of choice, while regimen-specific, evolving resistance complicates treatment sequencing and safety under liver-function constraints. Precision oncology for advanced HCC should therefore shift from regimen accumulation to implementation guidance: deploy multi-omic and dynamic biomarkers for patient stratification and risk-aware sequencing; target beyond PD-1/PD-L1 and VEGF axes to address oncogenic drivers and immune escape; and advance cure-oriented perioperative pathways with standardized definitions and evidence-based endpoints. Future work must focus on these three core directions: multi-omic biomarkers, novel therapeutic targets, and cure-oriented strategies.
No takes yet. Share an insight, caveat, or question.
Yuntao et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: